Eutilex.Co.,Ltd (KOSDAQ:263050)
959.00
+221.00 (29.95%)
At close: Feb 6, 2026
Eutilex.Co.,Ltd Market Cap
Eutilex.Co.,Ltd has a market cap or net worth of 35.32 billion as of March 10, 2026. Its market cap has decreased by -52.87% in one year.
Market Cap
35.32B
Enterprise Value
45.79B
Revenue
10.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
959.00
Market Cap Chart
Since December 24, 2018, Eutilex.Co.,Ltd's market cap has decreased from 567.29B to 35.32B, a decrease of -93.77%. That is a compound annual growth rate of -32.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kainos Medicine | 35.56B |
| Epibiotech | 33.33B |
| SCM Lifescience | 38.01B |
| ADBiotech | 29.72B |
| J2KBIO | 45.32B |
| MOA Life Plus | 27.14B |
| NGeneBio | 53.15B |
| EyeGene | 56.54B |